MedTrace Logo

Gut Microbiome and Blood Markers After Habitual Herbal Tea Consumption

NCT05862532 · Status: UNKNOWN · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 55

Last updated 2023-05-17

No results posted yet for this study

Summary

TeTrimTeas intends is to establish a long-term cooperative with local growers and producers who will become partners in the business, with profit share to local growers and producers. The overall aim of the company is to produce quality, science-based botanical/herbal teas to improve health and wellbeing, growing as many of the ingredients locally and organically, to reduce food-to-fork miles within the decarbonisation and sustainability agendas in Wales.

TeTrimTeas have created herbal green tea blends, improving on existing Chinese formulation, and would like to test it as 'health tea'. The recruited cohort will be randomised into one of three intervention teas (green tea control, senna herbal mix and rhubarb root herbal mix). They would like to explore if consumption of the teas for 21 days has an impact on digestion and potentially help control weight gain.

Aberystwyth University will use high resolution metabolomics to investigate the chemical composition of capillary blood samples, in particular the short chain fatty acids. They will also assess lipid composition in capillary bloods and the microbiome of stools. Diet data, stool consistency and anthropometric measurements will be collected pre and post intervention. Results will advance product development and data would be used in grant applications into the health benefits of the herbal teas.

Conditions

Interventions

DIETARY_SUPPLEMENT

TeTrimTeas welsh Herbal tea with rhubarb root

TeTrimTeas welsh Herbal tea with green tea and rhubarb root

DIETARY_SUPPLEMENT

TeTrimTeas welsh Herbal tea with senna

TeTrimTeas welsh Herbal tea with green tea and senna

DIETARY_SUPPLEMENT

TeTrimTeas welsh Herbal tea with green tea

TeTrimTeas welsh Herbal tea with green tea

Sponsors & Collaborators

  • TeTrimTeas Cyf

    collaborator UNKNOWN

  • Aberystwyth University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-11-17
Primary Completion
2022-12-10
Completion
2023-05-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05862532 on ClinicalTrials.gov